Papillary Carcinoma of Thyroid Recurring as Pleural Effusion 26 Years After Curative Therapy

Mundathaje, Uday; Murali, Ganesan; Ali, Hydar; Goldberg, Steven K.

doi:10.1378/chest.130.4_meetingabstracts.331s-b

Cited by 4 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Malignant pleural effusion caused by differentiated thyroid cancer with definite pleura metastasis is exceedingly rare. Only 2 cases have been reported and the diagnoses were made by autopsy and pleural biopsy, respectively [3,4]. In this report, Hsu/Hsieh/Duh/Chien/Li/Shih we applied the cytology features and immunochemical methods to prove a patient with massive pleural effusion resulting from Hürthle cell carcinoma of the thyroid with potential pleural metastasis, and we review the published literature.…”

Section: Introductionmentioning

confidence: 99%

Hürthle Cell Carcinoma of the Thyroid with Contralateral Malignant Pleural Effusion

Hsu

Hsieh²,

Duh³

et al. 2009

Oncol Res Treat

View full text Add to dashboard Cite

Background: Thyroid cancers with pulmonary metastases have been well documented. However, malignant pleural effusion has rarely been reported. Case Report: We present a 77-year-old patient who had Hürthle cell carcinoma of the thyroid with contralateral malignant pleural effusion. The diagnosis was based on consistency in the histopathological and immunohistochemical features of pleural fluid cytology and the final pathology of the thyroid tumor. Results: The patient was treated with total thyroidectomy and postoperative radioactive-iodine ablation. Unfortunately, he died for recurrent pleural effusion and pulmonary complication 6 months later. Conclusion: Identifying the origin of malignant pleural effusion is important to provide treatment guidance. In this report, we review the literature on diagnosis and treatment of thyroid cancer with malignant pleural effusion.

show abstract

Section: Introductionmentioning

confidence: 99%

Hürthle Cell Carcinoma of the Thyroid with Contralateral Malignant Pleural Effusion

Hsu

Hsieh²,

Duh³

et al. 2009

Oncol Res Treat

View full text Add to dashboard Cite

show abstract

“…In some cases, PTC metastasis is detected many years after the initial diagnosis. For example, malignant pleural effusion developed 24 years after treatment for PTC in one case [ 2 ]. Most cases of malignant pleural effusion of PTC involve parenchymal metastasis; pleural effusion and pleural metastasis are very rare without involvement of the parenchymal region.…”

Section: Discussionmentioning

confidence: 99%

Pleural metastasis of thyroid carcinoma diagnosed by thoracoscopy under local anesthesia

Noda

Murase

Otaki

et al. 2014

Respirology Case Reports

View full text Add to dashboard Cite

A 79-year-old male patient with no symptoms was referred to us with incidentally detected pleural effusion and nodules. He had previously been diagnosed with papillary thyroid carcinoma (PTC) and had undergone left subtotal thyroidectomy 12 years before his referral. Four years after the operation, he experienced a relapse limited to the cervical lymph node and was treated with neck dissection. He experienced no further recurrence until his referral. Thoracoscopy was performed under local anesthesia to confirm the diagnosis because thoracentesis was precluded by the small quantity of pleural effusion and the nodules. Many vivid red pleural masses were evident as was a small amount of bloody pleural effusion. The patient was diagnosed with pleural metastasis of PTC, which has a poor prognosis. Because of this poor prognosis, prompt diagnosis is essential. Thoracoscopy under local anesthesia can allow the prompt diagnosis of cases in which safe thoracentesis would be difficult.

show abstract

“…Immunohistochemistry with TTF-1 and thyroglobulin on cytology helps to differentiate metastatic adenocarcinoma lung from thyroid where in serum thyroglobulin is normal. 7 Typically, the presence of a malignant pleural effusion portends a dismal prognosis, with a reported median survival of 11 months. 2,4 Metastatic pleural effusion commonly seen in papillary carcinoma thyroid except one case report of hurtle cell carcinoma (Figs 3 and 4).…”

Section: Discussionmentioning

confidence: 99%

Papillary Thyroid Carcinoma with Malignant Pleural Effusion: Dilemma of Etiology

Siddappa¹

2010

International Journal of Head and Neck Surgery

View full text Add to dashboard Cite

Papillary carcinomas of thyroid generally have an indolent course with metastatic disease in less than 5% of patients. Common sites of distant metastasis include lung and bone. A presentation with malignant pleural effusion is exceedingly rare with only a handful of cases reported in literature. We present a case and discuss the treatment of a patient presenting of papillary thyroid cancer with a relapse of the disease in the pleural cavity. There are no standard treatment recommendations in this setting in view of paucity of published data from literature.

show abstract

Papillary Carcinoma of Thyroid Recurring as Pleural Effusion 26 Years After Curative Therapy

Cited by 4 publications

References 2 publications

Hürthle Cell Carcinoma of the Thyroid with Contralateral Malignant Pleural Effusion

Hürthle Cell Carcinoma of the Thyroid with Contralateral Malignant Pleural Effusion

Pleural metastasis of thyroid carcinoma diagnosed by thoracoscopy under local anesthesia

Papillary Thyroid Carcinoma with Malignant Pleural Effusion: Dilemma of Etiology

Contact Info

Product

Resources

About